Swiss biotech Polyphor prices IPO at 38 Sfr per share

Spexis AG

14/05/2018 16:42

ZURICH, May 14 (Reuters) - Swiss biotech company Polyphor
 POLN.S  will raise 165 million Swiss francs ($165.4 million),
including an over-allotment option, after pricing shares in its
initial public offering at 38 Swiss francs each, the top end of
the indicated range, sources told Reuters on Monday.
    The company is due to make its debut on the Swiss stock
exchange on Tuesday in an all-primary share offering, the latest
in a raft of flotations in Switzerland this year.
    ($1 = 0.9976 Swiss francs)

 (Reporting by Oliver Hirt, writing by John Revill, Editing by
Michael Shields)
 ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;))